Ibafloxacin
Alternative Names: S 25930Latest Information Update: 05 Sep 1994
At a glance
- Originator 3M Pharmaceuticals
- Class Antibacterials; Quinolizines; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections